The purpose of this transmittal is to introduce Policy Number: HCDMA-19-001 which removes the PA requirements for MAT drug products that are prescribed and dispensed for the treatment of opioid use disorder (OUD) and alcohol use disorder (AUD).
dhcf
Department of Health Care Finance - DHCF
- Home
- Services
- District Health Care Coverage
- Long Term Care Admin
-
Providers
- Information for Doula Providers
- Important Notice for Primary Care Providers
- Alliance Program Changes-Providers
- Conflict-Free Case Management
- Division of Program Integrity (DPI)
- Medicaid Program Integrity
- Person-Centered Planning
- Provider Information and Forms
- Provider Performance
- Rates and Reimbursements
- Telemedicine
- Innovation
- Policies
- Ombudsman
-
About
- DC Medical Care Advisory Committee
- Beneficiary Advisory Council
- Meet Our Executive Team
- Publications and Forms
- Americans with Disabilities Act Information
- Grievances/Appeals
- Open Government and FOIA - DHCF
- Procurement Opportunities
- Grant Opportunities
- Director's Biography
- HIPAA - Notice of Privacy Practice
- DHCF Notice of Non-Discrimination and Accessibility Requirements Statement
- Innovation Initiatives
- Managed Care Quality Strategy
- Maternal Health Projects
- Perinatal Mental Health Task Force